Kestra Advisory Services, LLC - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.

Quarter-by-quarter ownership
Kestra Advisory Services, LLC ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$2,178,000
+35.9%
12,654
-0.9%
0.02%
+22.2%
Q2 2021$1,603,000
-7.4%
12,772
+0.1%
0.02%
-18.2%
Q1 2021$1,731,000
+4.2%
12,763
-1.8%
0.02%
+15.8%
Q4 2020$1,661,000
-99.9%
12,994
+1.6%
0.02%
-29.6%
Q3 2020$1,440,000,00012,7940.03%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,449,300$59,537,000,0006.61%
Foresite Capital Management II, LLC 188,602$7,748,0004.36%
Foresite Capital Management III, LLC 254,923$10,472,0003.43%
Artal Group S.A. 1,500,000$61,620,0002.49%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,305,174$53,617,0001.93%
Asymmetry Capital Management, L.P. 82,473$3,388,0001.84%
QVT Financial LP 190,977$7,845,0001.66%
SECTORAL ASSET MANAGEMENT INC 269,396$11,067,0001.32%
Sofinnova Investments, Inc. 241,043$9,902,0000.91%
Novo Holdings A/S 119,708$4,918,0000.69%
View complete list of ACCELERON PHARMA INC shareholders